News

BIOTRONIK SE & Co. KG announced the start of the NORDIC ICD clinical trial. The first implantable cardioverter defibrillator (ICD) patients were enrolled by its coordinating clinical investigator, Prof. Dr. Dietmar Bänsch at the...

Study to be Presented at the Heart Rhythm Society Annual Scientific Meeting in San Francisco This Spring NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced that the company has been invited by the Heart Rhythm...

Healthcare company introduces New Wireless Keyboard for iPad at the HiMSS Healthcare Conference Seal Shield LLC announced the new SILVER BLUE™ Bluetooth wireless keyboard and case for the iPad. The product has been designed specifically for...

LifeWatch AG announced an initiative with UnitedHealthcare Insurance Company, an affiliate of United-Health Group, that will provide members insured by UnitedHealthcare in-network access to LifeWatch cardiac monitoring services and...

Only one out of more than 1,900 people evaluated met the American Heart Association (AHA) definition of ideal cardiovascular health, according to a new study led by researchers at the University of Pittsburgh School of Medicine. Their...

Scottsdale Healthcare Shea Medical Center is the first hospital in the southwestern United States to implant an MRI-safe pacemaker, a major technological breakthrough for patients who need MRI diagnostic scans, which can damage older style...

The newly approved drug dabigatran is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation, according to updated guidelines from the American College of Cardiology, American Heart Association...

Cameron Health Inc. announced the first patient enrollment in the company's landmark EFFORTLESS S-ICD® System Registry by Dr. Marcoen Scholten, Medisch Spectrum Twente, Enschede, The Netherlands. The S-ICD System (Subcutaneous-Implantable...

In recognition of American Heart Month, the American College of Cardiology (ACC) released CardioSmart "Survival Guides" for five of the most common heart problems: coronary artery disease, heart failure, arrhythmia, hypertension and heart...

The World Heart Federation, sanofi-aventis and Boehringer Ingelheim have announced their collaboration on the AF AWARE (Atrial Fibrillation AWareness And Risk Education) campaign today, to raise awareness of atrial fibrillation (AF) and its...